- Home
- MATV vs SLP Comparison
MATV vs SLP Comparison
Compare MATV & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MATV | SLP |
|---|---|---|
| Founded | 1995 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | EDP Services |
| Sector | Basic Materials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.9M | 370.7M |
| IPO Year | 1996 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MATV | SLP |
|---|---|---|
| Price | $12.47 | $18.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | ★ 453.3K | 419.8K |
| Earning Date | 05-06-2026 | 04-09-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | $2.97 | $3.80 |
| Revenue Next Year | $4.20 | $5.90 |
| P/E Ratio | ★ N/A | $42.65 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $7.07 | $11.09 |
| 52 Week High | $15.48 | $21.01 |
Technical Indicators
Market Signals| Indicator | MATV | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 84.62 | 62.39 |
| Support Level | $7.58 | $18.18 |
| Resistance Level | $13.37 | $18.39 |
| Average True Range (ATR) | 0.46 | 0.06 |
| MACD | 0.29 | -0.06 |
| Stochastic Oscillator | 95.97 | 76.19 |
Price Performance
Historical ComparisonAbout MATV Mativ Holdings Inc.
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments, namely Filtration & advanced Materials, focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging, and healthcare solutions.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.